ArticlePlant physiology2026
Isopentenyl diphosphate isomerase exerts limited control over terpenoid biosynthesis in two woody plant species.
Article in Plant physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Terpenoid biosynthesis involves linear prenyl diphosphate intermediates of various chain lengths. These are constructed from 2 C5 precursors, the starter unit dimethylallyl diphosphate (DMADP) and the extender unit, isopentenyl diphosphate (IDP). Isopentenyl diphosphate isomerase (IDI) alters the DMADP:IDP ratio and may furnish a specific blend of C5 precursors appropriate for the length of intermediates being formed in each cellular compartment. We studied IDI in two woody plant species, Norway spruce (Picea abies) and gray poplar (Populus × canescens), whose major terpenoid specialized metabolites are of different sizes. While the catalytic parameters of IDI from each species measured in vitro were in line with the different C5 precursor demands, the DMADP:IDP ratios of both species in vivo did not differ. Moreover, although IDI silencing in both spruce and poplar increased IDP content and significantly decreased the DMADP:IDP ratio, it caused a few significant alterations in the content of downstream terpenoid pathway intermediates or products. Taken together, these results suggest that IDI exercises a limited control over the relative amounts of different size terpenoid products. Nevertheless, the elevated IDP content of both transgenic spruce and poplar lines was associated with dramatically increased emission of isoprenol and isoprenyl acetate. Feeding experiments with cultured poplar plants indicated that these metabolites were derived directly from IDP, and their formation could serve as a metabolic mechanism to reduce high intracellular accumulation of IDP. Such a mechanism can be considered analogous to the formation of isoprene as a way to reduce high concentrations of DMADP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.